Dealroom
Cover art for China's Tushen Zhihe raises hundreds of millions of yuan for AI protein design

China's Tushen Zhihe raises hundreds of millions of yuan for AI protein design

Chinese AI startup Tushen Zhihe secures hundreds of millions of yuan in funding for drug design innovation.

Nov 9, 2026

3 cards · 50s · tap to begin

From · · 50s

China's Tushen Zhihe raises hundreds of millions of yuan for AI protein design

Chinese AI startup Tushen Zhihe secures hundreds of millions of yuan in funding for drug design innovation.

In brief

Chinese AI startup Tushen Zhihe secures hundreds of millions of yuan in funding for drug design innovation. Tushen Zhihe, a Chinese AI protein-design startup, raised hundreds of millions of yuan across Pre-A and Pre-A+ rounds to advance drug development through AI. Originally reported by Dealroom.

Funding Round

Tushen Zhihe raised hundreds of millions of yuan across Pre-A and Pre-A+ rounds with Shanghai STVC Group leading the Pre-A round.

AI Drug Design Focus

The company builds ai models to design proteins for drugs targeting hard-to-drug targets like gpcrs, antibodies, and cyclic peptides.

Next Steps

Next Steps

Tushen Zhihe will push in-house pipelines toward investigational new drug filings, upgrade ai tools, and expand teams to partner with drugmakers.

In short

Tushen Zhihe, a Chinese AI protein-design startup, raised hundreds of millions of yuan across Pre-A and Pre-A+ rounds to advance drug development through AI.

Read the original on Dealroom

Read the TL;DR — this story on one card.

More news from China

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on tushen zhihe and related topics.